PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

32.00 / 12.87K

Day Range

- - -

52 Wk Range

0.00 - 0.20

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Pressure Biosciences Inc News

Toni Braxton Cheers PBIO's Acquisition Of CBD Co. Uncle Bud's (UPDATED)

Editor's note: The headline and body of this story have been updated to use a more specific industry descriptor (CBD).

Javier Hasse

CBD To Extend Shelf-Life Of Fresh Produce? This Company Is Working On It

Pressure BioSciences, Inc. (OTCQB: PBIO) announced today the initiation of studies to evaluate and demonstrate its industrially-scalable UltraShear Technology platform for producing oil-in-water nanoemulsions in the preparation of edible coatings of Nano-CBD

Vuk Zdinjak

Partner Content

Pressure BioScience's Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux

Often considered recession-proof, the life sciences sector faced a surprising amount of uncertainty over the past few years with up to 80% of companies saying they’ve been negatively impacted by the macroeconomic conditions that have shaken markets a

Partner Content

CBD Oil's Health Benefits Are Reportedly Locked Behind Poor Absorption Rates — This Pressure-Based Tech Company Says It's Found The Key

As the cannabis market moves steadily toward widespread legalization and acceptance, cannabidiol (CBD), one of the key medicinal compounds derived from the hemp plant, is appearing as an ingredient in more and more mainstream products.

Partner Content

Pressure BioSciences Wins $1.5 Million Contract From CBD Supply MD To Bring A Potent Nano-CBD Topical Spray To Store Shelves In April

This week, Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO”) announced that it had received a $1.5 million contract for its breakthrough CBD nanoemul

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-4.43M

Investing Cash Flow (TTM)

-4.50K

Financing Cash Flow (TTM)

4.42M

Free Cash Flow (TTM)

-4.43M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-10.72K

Valuation Metrics

Enterprise Value

$29.18M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.00

PB Ratio (TTM)

Earnings Yield % (TTM)

-830000.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.91

Company Debt

Total Debt

$28.63M

LT Debt

$160.49K

LT Debt Issuance (TTM)

$6.89M

LT Debt Repayment (TTM)

-$3.33M

Total Cash

$14.25K

Debt to Equity

Issuance of Debt (TTM)

$3.56M

Repayment of Debt (TTM)

-$1.63M

Key Statistics

Open

Volume / Avg.

32.00 / 12.87K

Day Range

- - -

52 Wk Range

0.00 - 0.20

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technolo...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

PBIO

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

PBIO

FAQ

How do I buy PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO) stock?

You can purchase shares of PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (OTCEM:PBIO) through any online brokerage.

View our list of the best stock brokerages

Who are PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO) competitors?

There are no as such competitors for PRESSURE BIOSCIENCES by Pressure BioSciences, Inc..

What is the forecast, or price target, for PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO) stock?

There is no analysis for PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. to provide a consensus price target.

What is the current price for PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO)?

The stock price for PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (OTCEM: PBIO) is $0.0001 last updated September 9, 2026 at 10:47 AM EDT.

Does PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO) pay a dividend?

There are no upcoming dividends for PRESSURE BIOSCIENCES by Pressure BioSciences, Inc..

When is PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (OTCEM:PBIO) reporting earnings?

PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. does not have any upcoming earnings scheduled.

Is PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO) going to split?

There is no upcoming split for PRESSURE BIOSCIENCES by Pressure BioSciences, Inc..

What sector and industry does PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. (PBIO) operate in?

PRESSURE BIOSCIENCES by Pressure BioSciences, Inc. is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the OTCEM.